Correct Answer: A. Talimogene laherparepvec
Explanation: Talimogene laherparepvec (T-VEC) is an FDA-approved injectable treatment for inoperable melanoma. It is an oncolytic herpes virus bioengineered with GM-CSF to invade and destroy melanoma tumor cells.
Reference: Harrington KJ, et al. Efficacy and safety of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor in patients with stage IIIB/C and IVM1a melanoma: subanalysis of the Phase III OPTiM trial. Onco Targets Ther. 2016;16:7081-93.
Don’t Agree? Tell us why in the comments section below.